Parapneumonic effusion and empyema.
Hamm H, Light RW.
Eur Respir J. 1997 May;10(5):1150-6. doi: 10.1183/09031936.97.10051150.
Diagnostic Value of C-Reactive Protein in Discrimination between Uncomplicated and Complicated Parapneumonic Effusion.
Kogan Y, Sabo E, Odeh M.
Diagnostics (Basel). 2020 Oct 15;10(10):829. doi: 10.3390/diagnostics10100829.
A study of the proteomic expression in patients with complicated parapneumonic pleural effusion.
Wu X, Yang W, Gou XH, Xu XY, Lu N, Jian SN, Han YJ, Lv TS, Luo LZ.
Arch Med Sci. 2021 Mar 21;19(5):1270-1280. doi: 10.5114/aoms/132885. eCollection 2023.
Parapneumonic Pleural Effusions and Empyema Thoracis.
Shebl E, Paul M.
2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Distinguishing complicated from uncomplicated parapneumonic effusions.
Porcel JM.
Curr Opin Pulm Med. 2015 Jul;21(4):346-51. doi: 10.1097/MCP.0000000000000164.
Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.
Li D, Shen Y, Qin J, Wan C, Zeng N, Chen L, Dong Y.
Ann Transl Med. 2019 Jan;7(1):1. doi: 10.21037/atm.2018.11.44.
A novel biomarker for pleural effusion diagnosis: Interleukin-36gamma in pleural fluid.
Guo L, Zhang Q, Lv C, Ma X, Song X, Huang J, Chen W, Li C, Ding Q.
J Clin Lab Anal. 2023 Jan;37(1):e24799. doi: 10.1002/jcla.24799. Epub 2022 Dec 7.
Evaluation and management of pleural sepsis.
Lui JK, Billatos E, Schembri F.
Respir Med. 2021 Oct;187:106553. doi: 10.1016/j.rmed.2021.106553. Epub 2021 Jul 28.
Factors influencing pleural drainage in parapneumonic effusions.
Porcel JM, Valencia H, Bielsa S.
Rev Clin Esp (Barc). 2016 Oct;216(7):361-366. doi: 10.1016/j.rce.2016.04.004. Epub 2016 May 6.
Evaluation of complicated and uncomplicated parapneumonic effusion in children.
Gayretli-Aydın ZG, Tanır G, Bayhan Gİ, Aydın-Teke T, Öz FN, Metin-Akcan Ö, Kaman A.
Turk J Pediatr. 2016;58(6):623-631. doi: 10.24953/turkjped.2016.06.008.
